“The application of edaravone dexborneol can significantly reduce the level of inflammatory factors and improve the neurological function in patients ...

On May 5, 2022, Simcere Pharmaceuticals (2096.HK) announced that，a phase 3 registrational clinical trial of Sanbexin Sublingual Tablet for the treatme...

On April 25, the Innovation Forum hosted by Simcere State Key Laboratory of Translational Medicine and Innovative Drugs was held in Nanjing and Boston...

The Chinese Society of Clinical Oncology (CSCO) Guidelines are recognized as the most authoritative clinical guidance and the “golden standard” in the...